Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy.

Fujii H, Iihara H, Kajikawa N, Kobayashi R, Suzuki A, Tanaka Y, Yamaguchi K, Yoshida K, Itoh Y.

Anticancer Res. 2017 Dec;37(12):6831-6837.

PMID:
29187462
2.

Efficacy of Single-dose First-generation 5-HT3 Receptor Antagonist and Dexamethasone for Preventing Nausea and Vomiting Induced by Low-dose Carboplatin-based Chemotherapy.

Kaito D, Iihara H, Funaguchi N, Endo J, Ito F, Yanase K, Toyoshi S, Sasaki Y, Hirose C, Arai N, Kitahora M, Ohno Y, Itoh Y, Minatoguchi S.

Anticancer Res. 2017 Apr;37(4):1965-1970.

PMID:
28373467
3.

Clinical Efficacy of Afatinib Treatment for a Patient with Leptomeningeal Carcinomatosis.

Kawaguchi Y, Hanaoka J, Hayashi H, Mizusaki N, Iihara H, Itoh Y, Sugiyama T.

Chemotherapy. 2017;62(3):147-150. doi: 10.1159/000454727. Epub 2016 Dec 29.

PMID:
28030859
4.

Control of Nausea and Vomiting in Patients with Colorectal Cancer Receiving Chemotherapy with Moderate Emetic Risk.

Suzuki A, Kobayashi R, Fujii H, Iihara H, Takahashi T, Yoshida K, Itoh Y.

Anticancer Res. 2016 Dec;36(12):6527-6533.

PMID:
27919978
5.

Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis.

Imai H, Kaira K, Naruse I, Hayashi H, Iihara H, Kita Y, Mizusaki N, Asao T, Itoh Y, Sugiyama T, Minato K, Yamada M.

Cancer Chemother Pharmacol. 2017 Jan;79(1):209-213. doi: 10.1007/s00280-016-3201-9. Epub 2016 Nov 29.

PMID:
27900441
6.

Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer.

Fujii H, Iihara H, Suzuki A, Kobayashi R, Matsuhashi N, Takahashi T, Yoshida K, Itoh Y.

Cancer Chemother Pharmacol. 2016 Jun;77(6):1209-15. doi: 10.1007/s00280-016-3039-1. Epub 2016 Apr 22.

PMID:
27106835
7.

[Relationship between the Incidence of Hypomagnesemia and Acneiform Rash and the Therapeutic Effect of Anti-EGFR Monoclonal Antibody in Patients with Metastatic Colorectal Cancer].

Fujii H, Iihara H, Ishihara M, Matsuhashi N, Takahashi T, Yoshida K, Itoh Y.

Gan To Kagaku Ryoho. 2016 Feb;43(2):229-33. Japanese.

PMID:
27067688
8.

Comparison of the Control of Nausea and Vomiting among Several Moderately Emetic-Risk Chemotherapy Regimens.

Iihara H, Ishihara M, Fujii H, Yoshimi C, Yamada M, Suzuki A, Yamaguchi K, Futamura M, Yoshida K, Itoh Y.

J Cancer. 2016 Mar 18;7(5):569-75. doi: 10.7150/jca.13637. eCollection 2016.

9.

Prevention of radiation esophagitis by polaprezinc (zinc L-carnosine) in patients with non-small cell lung cancer who received chemoradiotherapy.

Yanase K, Funaguchi N, Iihara H, Yamada M, Kaito D, Endo J, Ito F, Ohno Y, Tanaka H, Itoh Y, Minatoguchi S.

Int J Clin Exp Med. 2015 Sep 15;8(9):16215-22. eCollection 2015.

10.

Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer.

Hayashi H, Kita Y, Iihara H, Yanase K, Ohno Y, Hirose C, Yamada M, Todoroki K, Kitaichi K, Minatoguchi S, Itoh Y, Sugiyama T.

Biomed Chromatogr. 2016 Jul;30(7):1150-1154. doi: 10.1002/bmc.3642. Epub 2015 Dec 1.

PMID:
26525154
11.

Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients.

Yamada M, Iihara H, Fujii H, Ishihara M, Matsuhashi N, Takahashi T, Yoshida K, Itoh Y.

Anticancer Res. 2015 Nov;35(11):6175-81.

PMID:
26504047
12.

Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy.

Iihara H, Fujii H, Yoshimi C, Yamada M, Suzuki A, Matsuhashi N, Takahashi T, Yoshida K, Itoh Y.

Int J Clin Oncol. 2016 Apr;21(2):409-418. doi: 10.1007/s10147-015-0908-2. Epub 2015 Oct 16.

13.

[Analysis of Pemetrexed Monotherapy in Advanced Non-Small Cell Lung Cancer Patients with Impaired Renal Function].

Funaguchi N, Nakajima Y, Kaito D, Yanase K, Ito F, Endo J, Morishita M, Asano M, Iihara H, Mori H, Ohno Y, Minatoguchi S.

Gan To Kagaku Ryoho. 2015 Jun;42(6):705-8. Japanese.

PMID:
26199241
14.
15.

[Evaluation of the efforts of pharmaceutical care services before medical examination at an outpatient cancer chemotherapy clinic].

Yoshimi C, Yamada M, Fujii H, Nishigaki M, Iihara H, Kitaichi K, Takahashi M, Kurahashi S, Takahashi T, Yoshida K, Itoh Y.

Gan To Kagaku Ryoho. 2013 Mar;40(3):349-54. Japanese.

PMID:
23507597
16.

Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant.

Aoki S, Iihara H, Nishigaki M, Imanishi Y, Yamauchi K, Ishihara M, Kitaichi K, Itoh Y.

Mol Clin Oncol. 2013 Jan;1(1):41-46. Epub 2012 Aug 27.

17.

A randomized controlled non-inferiority study comparing the antiemetic effect between intravenous granisetron and oral azasetron based on estimated 5-HT3 receptor occupancy.

Endo J, Iihara H, Yamada M, Yanase K, Kamiya F, Ito F, Funaguchi N, Ohno Y, Minatoguchi S, Itoh Y.

Anticancer Res. 2012 Sep;32(9):3939-47.

PMID:
22993341
18.

Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic.

Iihara H, Ishihara M, Matsuura K, Kurahashi S, Takahashi T, Kawaguchi Y, Yoshida K, Itoh Y.

J Eval Clin Pract. 2012 Aug;18(4):753-60. doi: 10.1111/j.1365-2753.2011.01665.x. Epub 2011 Mar 18.

PMID:
21414113
19.

Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy.

Fujii H, Iihara H, Yasuda K, Matsuura K, Takahashi T, Yoshida K, Itoh Y.

Med Oncol. 2011 Jun;28(2):488-93. doi: 10.1007/s12032-010-9487-2. Epub 2010 Mar 31.

PMID:
20354823
20.

Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.

Ishihara M, Iihara H, Okayasu S, Yasuda K, Matsuura K, Suzui M, Itoh Y.

Support Care Cancer. 2010 Dec;18(12):1531-8. doi: 10.1007/s00520-009-0775-3. Epub 2009 Nov 18.

PMID:
19921282
21.
22.

[A retrospective analysis of adverse events based on a dose and a schedule in patients who underwent paclitaxel- containing chemotherapy].

Yoshimura T, Hirade K, Iihara H, Ishihara M, Komori Y, Okayasu S, Matsuura K, Yasuda T, Itoh Y.

Gan To Kagaku Ryoho. 2008 Oct;35(10):1721-6. Japanese.

PMID:
18931576
23.

Suture-related keratitis caused by Corynebacterium macginleyi.

Suzuki T, Iihara H, Uno T, Hara Y, Ohkusu K, Hata H, Shudo M, Ohashi Y.

J Clin Microbiol. 2007 Nov;45(11):3833-6. Epub 2007 Oct 3.

24.

Rapid multiplex immunofluorescent assay to detect antibodies against Burkholderia pseudomallei and taxonomically closely related nonfermenters.

Iihara H, Niwa T, Shah MM, Nhung PH, Song SX, Hayashi M, Ohkusa K, Itoh Y, Makino S, Ezaki T.

Jpn J Infect Dis. 2007 Jul;60(4):230-4.

25.

dnaJ gene sequence-based assay for species identification and phylogenetic grouping in the genus Staphylococcus.

Shah MM, Iihara H, Noda M, Song SX, Nhung PH, Ohkusu K, Kawamura Y, Ezaki T.

Int J Syst Evol Microbiol. 2007 Jan;57(Pt 1):25-30.

PMID:
17220435
26.

The dnaJ gene as a novel phylogenetic marker for identification of Vibrio species.

Nhung PH, Shah MM, Ohkusu K, Noda M, Hata H, Sun XS, Iihara H, Goto K, Masaki T, Miyasaka J, Ezaki T.

Syst Appl Microbiol. 2007 Jun;30(4):309-15. Epub 2007 Jan 4.

PMID:
17207598
27.

Legionella impletisoli sp. nov. and Legionella yabuuchiae sp. nov., isolated from soils contaminated with industrial wastes in Japan.

Kuroki H, Miyamoto H, Fukuda K, Iihara H, Kawamura Y, Ogawa M, Wang Y, Ezaki T, Taniguchi H.

Syst Appl Microbiol. 2007 Jun;30(4):273-9. Epub 2007 Jan 2.

PMID:
17197147
28.
29.

Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections.

Iihara H, Suzuki T, Kawamura Y, Ohkusu K, Inoue Y, Zhang W, Monir Shah M, Katagiri Y, Ohashi Y, Ezaki T.

Diagn Microbiol Infect Dis. 2006 Nov;56(3):297-303. Epub 2006 Jun 12.

PMID:
16769192
30.

Corynebacterium resistens sp. nov., a new multidrug-resistant coryneform bacterium isolated from human infections.

Otsuka Y, Kawamura Y, Koyama T, Iihara H, Ohkusu K, Ezaki T.

J Clin Microbiol. 2005 Aug;43(8):3713-7.

31.

[Management of the cervical area in preparation for crown restoration].

Kusakari H, Iihara H.

Nihon Shika Ishikai Zasshi. 1983;35(12):1301-8. Japanese. No abstract available.

PMID:
6576076
32.

[Problems of thermosetting resins for veneered crown--practical technique].

Kusakari H, Iihara H, Minagawa Y, Kushiro M, Uenoyama T.

Shikai Tenbo. 1982 Jun;59(7):1329-36. Japanese. No abstract available.

PMID:
6750818
33.

[Problems of thermosetting resins for veneered crowns. Clinical observations (author's transl)].

Kusakari H, Iihara H, Minagawa Y, Kushiro M, Uenoyama T.

Shikai Tenbo. 1982 Mar;59(3):533-41. Japanese. No abstract available.

PMID:
6952590

Supplemental Content

Loading ...
Support Center